ICUIICUIHealthcare · Medical Instruments & Supplies

ICUI Stock Forecast: ICU Medical, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$173
−1.84% on the day

The 7 Wall Street analysts covering ICU Medical, Inc. hold a median 12-month price target of $195 — +13.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 95 of 100 as at 21 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$4.3B
Ticker Nerd rank
95/ 100
Median analyst target
$195
Analysts covering
7
Revenue$551.7M+0.5% y/y
Operating income$60.4M
Net income$19.1M
Free cash flow$60.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−3.8%
1M
+7.1%
YTD
+20.9%
1Y
+28.4%
From 52W high
−7.9%
From 52W low
+49.4%
$115
$187
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores ICU Medical, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
95/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
93
Volatility
89
Issuance
81
Accruals
80
Momentum
79
Revisions
78
Quality
63
Growth
58

Value (93): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Growth (58): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

ICUI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ICUI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$120$140$160$180$200$220Jan 26Apr 26Jul 26Oct 26ICUIHigh $210Median $195Low $178

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says7 analysts
6
Buy
1
Hold
0
Sell
$178
Low
$195
Median
$210
High

The green dot is the last close — the median target sits +13.0% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 6 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
6 Nov 2026KeybancMaintainsOverweight$187 → $189
6 Nov 2026Piper SandlerMaintainsOverweight$195 → $200
7 Aug 2026BTIGMaintainsBuy$170 → $200
7 Aug 2026KeybancMaintainsOverweight—
7 Aug 2026NeedhamMaintainsBuy$165 → $187
7 Aug 2026Piper SandlerMaintainsOverweight$163 → $195
21 July 2026KeybancMaintainsOverweight$164 → $182
15 June 2026BTIGInitiatesBuy$170
27 May 2026NeedhamUpgradeBuy—
27 Apr 2026KeybancMaintainsOverweight—
17 Apr 2026Piper SandlerMaintainsOverweight—
20 Feb 2026KeybancMaintainsOverweight—
20 Feb 2026Piper SandlerMaintainsOverweight—
7 Nov 2025KeybancMaintainsOverweight—
7 Nov 2025Piper SandlerMaintainsOverweight—
21 Oct 2025KeybancMaintainsOverweight—
10 Sept 2025Piper SandlerMaintainsOverweight—
15 Aug 2025Piper SandlerInitiatesOverweight—
8 Aug 2025Raymond JamesMaintainsStrong Buy—
9 May 2025Raymond JamesMaintainsStrong Buy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ICUI.

Market Radar

This page is one stock. Monday covers all of them.

ICUI appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

ICUI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, ICU Medical, Inc. returned +28.4% against +6.9% for the S&P 500, dividends included.

ICUI vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140Jan 26Apr 26Jul 26Oct 26ICUIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ICUI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+2.1%
Analysts raising
6
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
72.2×

Cheaper than 11% of US stocks

Price / sales
2.0×

Cheaper than 49% of US stocks

Price / book
2.0×

Cheaper than 44% of US stocks

EV / EBITDA
15.1×

Cheaper than 34% of US stocks

Growth & margins
Revenue growth (YoY)
4.4%

Higher than 39% of US stocks

Earnings growth (YoY)
—
Gross margin
42.6%

Higher than 53% of US stocks

Operating margin
6.7%

Higher than 57% of US stocks

Net margin
2.8%

Higher than 51% of US stocks

Returns & dividend
Return on equity
2.8%

Higher than 48% of US stocks

Return on assets
2.3%

Higher than 59% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • ICU Medical, Inc. has a market value of $4.3B and an enterprise value of $5.2B.

  • Revenue in the twelve months to 30 June 2026: $2.2B. The latest quarter grew 0.5% year on year.

  • Net income over the same four quarters: $30.1M, a 1.4% net margin.

  • Diluted earnings per share, trailing twelve months: $1.18.

  • Free cash flow in the twelve months to 30 June 2026: $144.8M.

  • Shares outstanding: 25.0M.

  • Trailing P/E: 72.2×; forward P/E: 17.8× — the forward figure prices analyst consensus estimates, not reported earnings.

  • ICU Medical, Inc. employs 13,000 people — $166K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

ICUI and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
ICUIICU Medical, Inc.$4.3B95
STVNStevanato Group SpA$4.3B59
MMEDMiniMed Group, Inc.$4.5B1
NVSTEnvista Holdings Corp.$3.7B96
MMSIMerit Medical Systems, Inc.$5.0B86
PLSEPulse Biosciences, Inc.$3.3B54
WRBYWarby Parker, Inc.$2.9B28

Take a look at ICUI’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own ICU Medical, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about ICUI

What is the ICUI stock price forecast for 2026-2027?

The 7 Wall Street analysts covering ICU Medical, Inc. have a median 12-month price target of $195, with estimates ranging from $178 to $210. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ICUI stock a buy right now?

Of the 7 analysts covering ICU Medical, Inc., 6 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks ICU Medical, Inc. 95 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ICUI?

As at 21 Nov 2026, ICU Medical, Inc. ranks 95 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Value (93 of 100).

Will ICUI stock go up?

No one can know that. What the data says: the median 12-month target from 7 analysts implies +13.0% from the last close, and Ticker Nerd's factor model ranks ICU Medical, Inc. 95 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ICUI stock forecast for 2030?

No analyst covering ICU Medical, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ICUI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $178 to $210 over the next 12 months.

How has ICUI stock performed over the past year?

ICU Medical, Inc. returned +28.4% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does ICU Medical, Inc. do?

ICU Medical, Inc. is a medical technology company focused on infusion therapy, vascular access, and vital care products. ICU Medical develops, manufactures, and sells a broad portfolio that includes IV pumps, needlefree connectors, IV administration sets, sterile IV solutions, closed-system transfer devices for hazardous drugs, and safety software used in hospital and alternate care settings.

Company

About ICU Medical, Inc.

ICU Medical, Inc. is a medical technology company focused on infusion therapy, vascular access, and vital care products. ICU Medical develops, manufactures, and sells a broad portfolio that includes IV pumps, needlefree connectors, IV administration sets, sterile IV solutions, closed-system transfer devices for hazardous drugs, and safety software used in hospital and alternate care settings. The company also offers hemodynamic monitoring, respiratory, anesthesia, temperature management, and other critical care products that support clinical workflows and patient safety. Its product families are designed to help healthcare providers deliver medications and fluids, reduce contamination risks, and improve efficiency across the IV continuum of care. ICU Medical serves acute care hospitals, ambulatory clinics, and home or alternate-site care environments, making it an important supplier in medical devices and hospital infrastructure.

CEO Mr. Vivek Jain · 13,000 employees · United States · https://www.icumed.com